These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15681799)

  • 1. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
    Venti A; Giordano T; Eder P; Bush AI; Lahiri DK; Greig NH; Rogers JT
    Ann N Y Acad Sci; 2004 Dec; 1035():34-48. PubMed ID: 15681799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
    Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
    J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.
    Rogers JT; Randall JD; Cahill CM; Eder PS; Huang X; Gunshin H; Leiter L; McPhee J; Sarang SS; Utsuki T; Greig NH; Lahiri DK; Tanzi RE; Bush AI; Giordano T; Gullans SR
    J Biol Chem; 2002 Nov; 277(47):45518-28. PubMed ID: 12198135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.
    Bandyopadhyay S; Huang X; Cho H; Greig NH; Youdim MB; Rogers JT
    J Neural Transm Suppl; 2006; (71):237-47. PubMed ID: 17447434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
    Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein.
    Morse LJ; Payton SM; Cuny GD; Rogers JT
    J Mol Neurosci; 2004; 24(1):129-36. PubMed ID: 15314261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.
    Bandyopadhyay S; Cahill C; Balleidier A; Huang C; Lahiri DK; Huang X; Rogers JT
    PLoS One; 2013; 8(7):e65978. PubMed ID: 23935819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA.
    Bandyopadhyay S; Ni J; Ruggiero A; Walshe K; Rogers MS; Chattopadhyay N; Glicksman MA; Rogers JT
    J Biomol Screen; 2006 Aug; 11(5):469-80. PubMed ID: 16928984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease.
    Maloney B; Ge YW; Greig N; Lahiri DK
    FASEB J; 2004 Aug; 18(11):1288-90. PubMed ID: 15208260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease.
    Lahiri DK; Ge YW; Maloney B
    FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Iron-Response Elements of the mRNAs for the Alzheimer's Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity.
    Rogers JT; Xia N; Wong A; Bakshi R; Cahill CM
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region.
    Ge YW; Ghosh C; Song W; Maloney B; Lahiri DK
    J Neurochem; 2004 Sep; 90(6):1432-44. PubMed ID: 15341527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells.
    Westmark PR; Shin HC; Westmark CJ; Soltaninassab SR; Reinke EK; Malter JS
    Neurobiol Aging; 2006 Jun; 27(6):787-96. PubMed ID: 16672170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.
    Shaw KT; Utsuki T; Rogers J; Yu QS; Sambamurti K; Brossi A; Ge YW; Lahiri DK; Greig NH
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7605-10. PubMed ID: 11404470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
    Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
    Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery targeted to the Alzheimer's APP mRNA 5'-untranslated region: the action of paroxetine and dimercaptopropanol.
    Payton S; Cahill CM; Randall JD; Gullans SR; Rogers JT
    J Mol Neurosci; 2003; 20(3):267-75. PubMed ID: 14501007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells.
    Zhang J; Mori A; Chen Q; Zhao B
    Neuroscience; 2006 Nov; 143(1):63-72. PubMed ID: 16962711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide.
    Utsuki T; Yu QS; Davidson D; Chen D; Holloway HW; Brossi A; Sambamurti K; Lahiri DK; Greig NH; Giordano T
    J Pharmacol Exp Ther; 2006 Aug; 318(2):855-62. PubMed ID: 16690718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.
    Rogers JT; Venkataramani V; Washburn C; Liu Y; Tummala V; Jiang H; Smith A; Cahill CM
    J Neurochem; 2016 Aug; 138(3):479-94. PubMed ID: 27206843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
    Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
    Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.